ABL Bio Balance Sheet Health
Financial Health criteria checks 3/6
ABL Bio has a total shareholder equity of ₩74.1B and total debt of ₩43.0B, which brings its debt-to-equity ratio to 58%. Its total assets and total liabilities are ₩160.1B and ₩86.1B respectively.
Key information
58.0%
Debt to equity ratio
₩43.00b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩71.17b |
| Equity | ₩74.08b |
| Total liabilities | ₩86.07b |
| Total assets | ₩160.14b |
Financial Position Analysis
Short Term Liabilities: A298380's short term assets (₩75.5B) exceed its short term liabilities (₩41.8B).
Long Term Liabilities: A298380's short term assets (₩75.5B) exceed its long term liabilities (₩44.3B).
Debt to Equity History and Analysis
Debt Level: A298380 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if A298380's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: A298380's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if A298380's interest payments on its debt are well covered by EBIT.